A new treatment for hepatitis C virus can reduce the effectiveness of certain HIV medications if taken together and vice versa, the FDA warned in a drug safety announcement. An interaction between the ...

The clearance rates for those coinfected with HIV and hepatitis C virus (HCV) are still higher than those with HCV alone. Direct-acting antivirals (DAAs) are a means of curing HCV with an efficacy of ...

Sofosbuvir, a hepatitis C treatment drug, can adversely interact with tenofovir disoproxil, a HIV treatment drug, according to research led by Bingfang Yan, PhD, professor of biomedical and ...

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Yahoo Racing is powered by Motorsport Network, providing expert reporting, analysis, and insider access across the world’s top racing series. The phase II study, which enrolled treatment-naïve HCV ...

People coinfected with HIV and hepatitis C virus remain at risk for hepatocellular carcinoma within 6 years of starting ...

Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

Atea Pharmaceuticals announced the ongoing enrollment in its Phase 3 C-BEYOND trial evaluating the combination of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV). Positive ...

Men who have sex with men who are living with HIV were found to have a significant burden of both hepatitis B and C infections. Patients who have HIV and HCV or HBV have shown a reduction in life ...